The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...

Recent U.S. decisions about vaccines signal bigger changes to come that could threaten the foundation of the national childhood immunization schedule.

Most Americans are confident that childhood vaccines are safe and effective, but new polling shows gaps in sentiment along ...

Nirsevimab is a long-acting monoclonal antibody that provides season-long protection against RSV in infants, reducing ...